Comment to the paper of Medeiros CAM, et al. (2007) J Neurol 254:459-464.
Fertl
Elisabeth
E
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D002492:Central Nervous System Depressants / Q000494:pharmacology / Q000627:therapeutic use; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D004334:Drug Administration Schedule; D004347:Drug Interactions / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D008550:Melatonin / Q000494:pharmacology* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications*; D015990:Placebo Effect; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D013997:Time Factors
D000978:Antiparkinson Agents; D002492:Central Nervous System Depressants; D007980:Levodopa; D008550:Melatonin